Vaccine Sites Scramble To Pause Use Of J&J Covid-19 Vaccine

The video discusses the distribution of the Johnson & Johnson COVID-19 vaccine and the quick state-level decisions that led to a scramble at clinics. The CDC and FDA are investigating a rare blood clotting condition linked to the J&J vaccine, with only six cases reported among nearly 7 million doses. The White House reassures that the pause will not affect the vaccination pace, as there is enough supply of Pfizer and Moderna vaccines. Clinics, like the one in Arlington, Virginia, are adjusting by offering Moderna instead of J&J, ensuring appointments are not canceled. The pause on J&J is a recommendation while the investigation continues.

What prompted the vaccine clinics in Virginia to switch from Johnson & Johnson to Moderna?

• A state-level decision

• A federal mandate

• A shortage of J&J vaccines

• Public demand for Moderna

What is the main concern being investigated by the CDC and FDA regarding the J&J vaccine?

• Its effectiveness against new variants

• A potential link to a rare blood clotting condition

• The duration of immunity it provides

• Its storage requirements

How did the White House reassure the public about the vaccine supply?

• By increasing the production of J&J vaccines

• By confirming sufficient supply of Pfizer and Moderna vaccines

• By importing vaccines from other countries

• By extending the shelf life of existing vaccines

What was the reaction of recipients who were expecting the J&J vaccine but received Moderna instead?

• They demanded a refund

• They refused the Moderna vaccine

• They were indifferent about the change

• They were relieved to still have an appointment

What was the impact of the vaccine switch on second dose appointments?

• They were canceled

• They were postponed

• They continued as planned

• They were moved to a different location